Bright Green Corporation Announces the completion of its restructuring plan, withdraws from the Cannabis business and sets course on the production of all DEA Scheduled Controlled Substances
25 February 2025 - 1:15AM
Bright Green Corporation (OTC: BGXX) (“Bright Green” or the
“Company”) announced that on February 24, 2025, on behalf of the
Company, Lynn Stockwell has asked the court to approve the “RSA”
Restructuring Security Agreement. The highlights of the RSA will
provide new equity for the company to pay all creditors with
approved claims in full, in addition the Company equity
shareholders will retain their interests in the Company and are
unimpaired with no dilution.
The Company in its restructuring efforts has
entered into an agreement with the DEA to immediately withdraw all
Cannabis related renewal applications. This agreement will allow
for reinstatement once the Company is satisfied that there is
commercial value, and the federal government clarifies a path that
will stabilize operations for medical research and possible drug
development.
Lynn Stockwell, the new Chief Executive
Officer and Chairman of the Board of Directors of the Company also
sponsors and manages other public corporations that are building a
financial war chest to be used for acquisitions of revenue
generating, well managed corporations for the platform of onshoring
controlled substance production, API and manufacturing back to the
U.S.
Stockwell said, “the Company will not canvas
equity and then jeopardize shareholder value by the uncertainty of
the United States Cannabis industry, currently this is not a
business where normal banking is prohibited. I have reset the
course for Bright Green to become the first mover in the production
of legal Controlled Substances for medical purpose establishing a
reliable API supply chain”
These legal controlled substances have never
been produced commercially in the United States. The critical
supply is imported from countries where diversion and quality
controls are not a priority.
Lynn Stockwell continues, “this new federal
administration is actively positioning Bright Green to participate
in the production, drug manufacturing and prescription drug
delivery back to the United States. This creates an opportunity for
Bright Green where the drugs purchased in the United States has a
total addressable market of hundreds of billions of dollars.
With likely tariffs protecting this new American industry and
supply contracts the company will move forward to implement its
planned owner/operator operations for a $3.5 billion dollar
investment. The owner/operators will implement this capital to
build new DEA and FDA compliant mega farms for the production
facilities to produce controlled substances that can supply quality
API by contract for the MADE IN AMERICA supply chain. Each American
farmer owner/operator will have access to federal loan guarantees
to support the new infrastructure that is expected to create
thousands of new jobs for the infrastructure construction while
fostering the Company’s EB-5 program with investment through legal
immigration for this new business. The Company will continue its
exclusive partnership with Asia Capital Pioneer Group Inc to help
support its EB-5 marketing efforts across Asia and the
world.”
Gurvinder Singh will rejoin the Company as
General Manager responsible for the EB-5 program administered by
Bright Green Regional Center LLC and help direct the Company
forward.
The Company’s planned revenue is from contracts
for production of controlled substances and EB-5 investment, the
$800,000 investment from applicants seeking a green card
administered by the USCIS EB-5 program that could generate
significant capital from qualified applicants that seek entry into
the United States through legal immigration.
The Company believes that the timing for both
revenue streams will create this opportunity and Bright Green
Corporation will reset in a very positive way immediately.
Cautionary Note Regarding Forward-Looking Statements
This press release contains “forward-looking
statements” within the meaning of the “safe harbor” provisions of
the Private Securities Litigation Reform Act of 1995. These
forward-looking statements are made as of the date they were first
issued and were based on current expectations, estimates, forecasts
and projections as well as the beliefs and assumptions of
management as of such date. Words such as “expect,” “anticipate,”
“should,” “believe,” “hope,” “target,” “project,” “goals,”
“estimate,” “potential,” “predict,” “may,” “will,” “might,”
“could,” “intend,” “shall” and variations of these terms or the
negative of these terms and similar expressions are intended to
identify these forward-looking statements. Forward-looking
statements are subject to a number of risks and uncertainties, many
of which involve factors or circumstances that are beyond the
Company’s control. Such forward looking statements include, but are
not limited to, the ability of the Company to implement the Plan
and raise funds under the Company’s EB-5 program, the impact that
new officers, directors and employees may have on the Company and
the Company’s business and results of operations. The Company’s
actual results could differ materially from those stated or
implied
Source:
Bright Green Corporation401 E Las Olas Blvd #1400Fort
Lauderdale, Florida 33301(833) 658-1799
Bright Green (NASDAQ:BGXX)
Historical Stock Chart
From Feb 2025 to Mar 2025
Bright Green (NASDAQ:BGXX)
Historical Stock Chart
From Mar 2024 to Mar 2025